Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy

Journal of Human Genetics

Volumn 52, Issue 4, 2007, Pages 328-333

  Myoumoto, Akira ^a   Nakatani, Kaoru ^a   Koshimizu, Taka Aki ^a   Matsubara, Hiroshi ^a   Adachi, Souichi ^a   Tsujimoto, Gozoh ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Acute lymphoblastic leukemia; Apoptosis; Drug resistance; Glucocorticoid; Granzyme A; Targeted therapy

Indexed keywords

GLUCOCORTICOID; GRANZYME A;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PROTEIN EXPRESSION;

CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GLUCOCORTICOIDS; GRANZYMES; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; RNA, MESSENGER;

EID: 33947683196     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-007-0119-4     Document Type: Article

References (19)

1. Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Korholz D, Graubner U, Haas RJ, Jorch N, Spaar HJ, Kaspers GJ, Kamps WA, Van der Does-Van den Berg A, Van Wering ER, Veerman AJ, Janka-Schaub GE (2003) Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol 21:3262-3268
2. Dordelmann M, Reiter A, Borkhardt A, Ludwig WD, Gotz N, Viehmann S, Gadner H, Riehm H, Schrappe M (1999) Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 94:1209-1217
3. Holleman A, den Boer ML, Kazemier KM, Janka-Schaub GE, Pieters R (2003) Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood 102:4541-4546
4. Igarashi S, Manabe A, Ohara K, Kumagai M, Saito T, Okimoto Y, Kamijo T, Isoyama K, Kajiwara M, Sotomatsu M, Sugita K, Sugita K, Maeda M, Yabe H, Kinoshita A, Kaneko T, Hayashi Y, Ikuta K, Hanada R, Tsuchida M (2005) No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol. J Clin Oncol 23:6489-6498
5. Inukai T, Sugita K, Mitsui K, Iijima K, Goi K, Tezuka T, Kojika S, Kagami K, Mori T, Kinoshita A, Suzuki T, Okazaki-Koyama T, Nakazawa S (2000) Participation of granulocyte colony-stimulating factor in the growth regulation of leukemia cells from Philadelphia chromosome-positive acute leukemia and blast crisis of chronic myeloid leukemia. Leukemia 14:1386-1395
6. Ito C, Evans WE, McNinch L, Coustan-Smith E, Mahmoud H, Pui CH, Campana DJ (1996) Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Clin Oncol 8:2370-6
7. Miyashita T, Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151-157
8. Ohyashiki K, Miyauchi J, Ohyashiki JH, Saito M, Yaguchi M, Inatomi Y, Nakazawa S, Waca H, Mizutani S, Matsuo Y (1993) Interleukin-7 enhances colony growth and induces CD20 antigen of a Ph+ acute lymphoblastic leukemia cell line, OM9;22. Leukemia 7:1034-1040
9. Okada M, Adachi S, Imai T, Watanabe K, Toyokuni SY, Ueno M, Zervos AS, Kroemer G, Nakahata T (2004) A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity. Blood 103:2299-2307
10. Pegoraro L, Matera L, Ritz J, Levis A, Palumbo A, Biagini G (1983) Establishment of a Ph1-positive human cell line (BV173). J Natl Cancer Inst 70:447-453
11. Pui CH, Evans WE (2005) Treatment of acute lymphoblastic leukemia. N Engl J Med 354:166-178
12. Pui CH, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350:1535-1548
13. Ruike Y, Katsuma S, Hirasawa A, Tsujimoto G (2006) Glucocorticoid-induced alternative promoter usage for a novel 5′ variant of granzyme A. J Hum Genet. December 19 2006; (Epub ahead of print)
14. Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R (2004) Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 11(Suppl 1):S45-S55
15. Turner AK, Carroll CJ, Pinkus JL, Charles D, Chattoraj SC (1973) Simultaneous competitive protein binding assay for cortisol, cortisone, and prednisolone in plasma, and its clinical application. Clin Chem 19:731-736
16. U M, Shen L, Oshida T, Miyauchi J, Yamada M, Miyashita T (2004) Identification of novel direct transcriptional targets of glucocorticoid receptor. Leukemia 18:1850-1856
17. Yamada M, Hirasawa A, Shiojima S, Tsujimoto G (2003) Granzyme A mediates glucocorticoid-induced apoptosis in leukemia cells. FASEB J 17:1712-1714
18. Yamada M, Katsuma S, Adachi T, Hirasawa A, Shiojima S, Kadowaki T, Okuno Y, Koshimizu TA, Fujii S, Sekiya Y, Miyamoto Y, Tamura M, Yumura W, Nihei H, Kobayashi M, Tsujimoto G (2005) Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis. Proc Natl Acad Sci USA 102:7736-7741
19. Yamamoto K, Seto M, Iida S, Komatsu H, Kamada N, Kojima S, Kodera Y, Nakazawa S, Saito H, Takahashi T, Ueda R (1994) A reverse transcriptase- polymerase chain reaction detects heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities. Blood 83:2912-2921